SHILPAMED — Shilpa Medicare Share Price
0.000.00%
Last trade - 00:00- IN₹52.27bn
- IN₹60.53bn
- IN₹10.50bn
- 58
- 17
- 98
- 63
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.79 | ||
| PEG Ratio (f) | 1.11 | ||
| EPS Growth (f) | 41.74% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.93 | ||
| Price to Tang. Book | 4.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.65 | ||
| EV to EBITDA | 28.5 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.44% | ||
| Return on Equity | -0.04% | ||
| Operating Margin | 9.39% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 7,333.88 | 9,079.1 | 9,011.3 | 11,455.23 | 10,501.12 | 13,206 | 14,576 | 5.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +21.85 | +21.61 | -34.28 | -46.35 | n/a | n/a | +41.74 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 20th, 1987
- Public Since
- March 31st, 1995
- No. of Shareholders
- 46,869
- No. of Employees
- 1,033
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 97,790,908
- Address
- Shilpa House, RAICHUR, 584135
- Web
- https://www.vbshilpa.com/
- Phone
- +91 8532238704
- Auditors
- Bohra Bhandari Bung & Associates
Upcoming Events for SHILPAMED
Q1 2025 Shilpa Medicare Ltd Earnings Release
Shilpa Medicare Ltd Annual Shareholders Meeting
Similar to SHILPAMED
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Shilpa Medicare share price?
As of Today at 19:19 UTC, shares in Shilpa Medicare are trading at IN₹534.55. This share price information is delayed by 15 minutes.
How has the Shilpa Medicare share price performed this year?
Shares in Shilpa Medicare last closed at IN₹534.55 and the price had moved by +109.18% over the past 365 days. In terms of relative price strength the Shilpa Medicare share price has outperformed the S&P BSE 100 Index by +62.24% over the past year.
What are the analyst and broker recommendations for Shilpa Medicare?
The overall consensus recommendation for Shilpa Medicare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Shilpa Medicare dividend yield?
Shilpa Medicare does not currently pay a dividend.
Does Shilpa Medicare pay a dividend?
Shilpa Medicare does not currently pay a dividend.
When does Shilpa Medicare next pay dividends?
Shilpa Medicare does not currently pay a dividend.
How do I buy Shilpa Medicare shares?
To buy shares in Shilpa Medicare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shilpa Medicare?
As of the previous close price of IN₹534.55, shares in Shilpa Medicare had a market capitalisation of IN₹52.27bn.
Where are Shilpa Medicare shares listed?
Here are the trading details for Shilpa Medicare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SHILPAMED
What kind of share is Shilpa Medicare?
Based on an overall assessment of its quality, value and momentum Shilpa Medicare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shilpa Medicare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Shilpa Medicare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shilpa Medicare. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +36.81%.
As of the last closing price of IN₹534.55, shares in Shilpa Medicare were trading +44.14% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shilpa Medicare PE Ratio?
The Shilpa Medicare PE ratio based on its reported earnings over the past 12 months is 32.79. The shares last closed at IN₹534.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shilpa Medicare?
Shilpa Medicare's management team is headed by:
- Omprakash Inani - NEC
- Alpesh Dalal - CFO
- Vishnukant Bhutada - MDR